85 structural-engineering-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dip" research jobs at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
About us: King’s Telecoms Group has been part of the global ecosystem which designed and deployed telecoms technology, from 2G to 5G, and now 6G. King’s Telecoms Group has become a flagship hub of
-
24 Dec 2025 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Literature Engineering Geography Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1
-
11 Dec 2025 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Architecture Engineering Computer science Mathematics Physics Researcher Profile Recognised Researcher (R2) First
-
teaching, research and clinical practice is embedded across five Departments. More information: https://www.kcl.ac.uk/slcps About the role We are looking for a skilled biomedical scientist with a strong
-
Formstone (see Panousopoulou et al. J. Cell Sci. 2016 (https://doi.org/10.1242/jcs.180703) and Prof. Philippa Francis-West (Mao et al. Nature Comms. 2016 (https://doi: 10.1038/ncomms11469 and Prof. Philippa
-
About Us The post will be based at St Thomas’ Hospital in central London in the School of Biomedical Engineering & Imaging Sciences at King’s College London: https://www.kcl.ac.uk/bmeis . There is
-
information: https://www.kcl.ac.uk/slcps About the role We are looking for a skilled biomedical scientist with a strong interest in the human microbiome, clinical test development and have proven relevant
-
epidermis grow around the viscera. The work will be in close collaboration with Dr. Caroline Formstone (see Panousopoulou et al. J. Cell Sci. 2016 (https://doi.org/10.1242/jcs.180703) and Prof. Philippa
-
19 Dec 2025 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Architecture Literature Chemistry Engineering Mathematics Physics Researcher Profile Recognised Researcher (R2
-
synthesis of novel structures chosen from understanding of initial series of compounds and their performance from MRC grant MR/T015845/1) in terms of measurements of efficacy using a validated in vivo model